Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Prog Lipid Res. 2012 Mar 29;51(3):199–207. doi: 10.1016/j.plipres.2012.03.001

Table 1.

Bioactive lysophospholipids

LysoPLs Cellular effect Responding cell Receptor Ref
S1P Survival T-cells; B-cells; Macrophage S1P1-2,4 [3]
Migration T-cells; B-cells, Mast cells; Macrophages; Dendritic cells S1P1
Angiogenesis Endothelial cells S1P1
LPA Migration T-cells; Dendritic cells; Fibroblasts LPA1-3 [1]
Proliferation Neuronal cells; Astrocytes LPA1-2
Survival Neuronal cells; Endothelial cells; Leukocytes LPA1-2
LysoPC Calcium mobilization Neutrophils G2A [35]
T-cells G2A ? [77]
Enhance ROS Neutrophil ? [19, 78]
Inhibit ROS Neutrophil G2A [79]
Migration T-cells; Monocytes G2A [54, 80, 81]
LysoPS Degranulation Mast cells; Neutrophils GPR34; G2A [35, 42]
Enhance ROS Neutrophil ? [19, 78]
Calcium mobilization Neutrophils; T-cells G2A; ? [35, 82]
Leukemic cells ? [83]
Enhanced efferocytosis Macrophages G2A [22, 23]
Migration Fibroblasts ? [17]
Glioma cells ? [16]
Differentiation PC12 ? [84]
LysoPE Calcium mobilization Neutrophils G2A [35]
Migration Ovarian cancer cells ? [85]